Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
The Pharmacogenomics Journal
|
March 18, 2015
A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients
S Chen, I Laverdiere, A Tourancheau, et al.
Journal of Mass Spectrometry : JMS
|
March 3, 2017
Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma
S D'Aronco, M Dall'Armi, S Crotti, et al.
Critical Care Medicine
|
March 13, 1999
Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit
M De Cicco, F Macor, I Robieux, et al.
The Pharmacogenomics Journal
|
April 7, 2010
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy
E Cecchin, M Agostini, S Pucciarelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 15, 2017
SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder
M Toffoli, E Dreussi, E Cecchin, et al.
The Pharmacogenomics Journal
|
October 22, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin
E Cecchin, G Perrone, S Nobili, et al.
The Pharmacogenomics Journal
|
April 9, 2014
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
M M Dias, J-P Pignon, C S Karapetis, et al.
American Journal of Epidemiology
|
October 23, 2009
Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review
E Taioli, M A Garza, Y O Ahn, et al.
Clinical Pharmacology and Therapeutics
|
September 22, 2018
CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C H van der Wouden, A Cambon-Thomsen, E Cecchin, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2016
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C H van der Wouden, A Cambon-Thomsen, E Cecchin, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
The Pharmacogenomics Journal
|
March 18, 2015
A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients
S Chen, I Laverdiere, A Tourancheau, et al.
Journal of Mass Spectrometry : JMS
|
March 3, 2017
Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma
S D'Aronco, M Dall'Armi, S Crotti, et al.
Critical Care Medicine
|
March 13, 1999
Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit
M De Cicco, F Macor, I Robieux, et al.
The Pharmacogenomics Journal
|
April 7, 2010
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy
E Cecchin, M Agostini, S Pucciarelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 15, 2017
SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder
M Toffoli, E Dreussi, E Cecchin, et al.
The Pharmacogenomics Journal
|
October 22, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin
E Cecchin, G Perrone, S Nobili, et al.
The Pharmacogenomics Journal
|
April 9, 2014
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
M M Dias, J-P Pignon, C S Karapetis, et al.
American Journal of Epidemiology
|
October 23, 2009
Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review
E Taioli, M A Garza, Y O Ahn, et al.
Clinical Pharmacology and Therapeutics
|
September 22, 2018
CORRIGENDUM: Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C H van der Wouden, A Cambon-Thomsen, E Cecchin, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2016
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C H van der Wouden, A Cambon-Thomsen, E Cecchin, et al.
Page
of 9